SCHEMBL28527237

SCHEMBL28527237

NC[C@@H](Cl)c1ccccc1

nearest known ligand 0.59

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TAAR1 Q96RJ0 4/20 0.59
HTR2A P28223 3/20 0.59
TSHR P16473 2/20 0.50
CHRNB2 P17787 1/20 0.48
CHRNA4 P43681 1/20 0.48
HRH1 P35367 2/20 0.48
SLC6A4 P31645 2/20 0.45
SLC6A3 Q01959 2/20 0.45
SLC6A2 P23975 1/20 0.45
DPP4 P27487 2/20 0.43
F2 P00734 1/20 0.43
GABBR2 O75899 1/20 0.43
GABBR1 Q9UBS5 1/20 0.43
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2D6 P10635 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3406287 1.00 TAAR1 (0.59) TAAR1HTR2ATSHRCHRNB2CHRNA4
Hydrochloric Acid SCHEMBL8120982 0.97 TAAR1 (0.56) TAAR1HTR2ATSHRCHRNB2CHRNA4
SCHEMBL4377946 0.80 HRH1 (0.62) TAAR1HTR2ATSHRCHRNB2CHRNA4
Hydrochloric Acid SCHEMBL4374017 0.78 HRH1 (0.60) TAAR1HTR2ATSHRCHRNB2CHRNA4
SCHEMBL22042229 0.78 TSHR (0.55) TAAR1HTR2ATSHRHRH1DPP4
SCHEMBL9425022 0.78 TSHR (0.55) TAAR1HTR2ATSHRHRH1DPP4
SCHEMBL11460830 0.77 TSHR (0.48) TAAR1HTR2ATSHRHRH1SLC6A4
SCHEMBL3702383 0.77 TSHR (0.48) TAAR1TSHRSLC6A4SLC6A3GABBR2
SCHEMBL3317983 0.77 TSHR (0.48) TAAR1TSHRSLC6A4SLC6A3GABBR2
SCHEMBL3695940 0.77 TSHR (0.48) TAAR1TSHRSLC6A4SLC6A3GABBR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108250151-B Preparation method of ambrisentan 济南周行医药科技有限公司 2021-03-16 CN claimed
CN-108250151-B Preparation method of ambrisentan 济南周行医药科技有限公司 2021-03-16 CN disclosed